FABP1 deletion in hepatocytes attenuates both diet-induced hepatic steatosis and fibrogenesis, characteristics of NASH, whereas HSC-specific FABP1 deletion did not alter the fibrogenesis (130). This evidence concerns the gene FABP1 and metabolic dysfunction-associated steatohepatitis.